![Labor MP calls on government to widen Covid anti-viral eligibility in Australia | Health | The Guardian Labor MP calls on government to widen Covid anti-viral eligibility in Australia | Health | The Guardian](https://i.guim.co.uk/img/media/98b2156a1da462545f5c671ff47510c641d51bcf/0_85_3500_2100/master/3500.jpg?width=1200&height=900&quality=85&auto=format&fit=crop&s=dbfffccc45b67db3fb919a747741ba8a)
Labor MP calls on government to widen Covid anti-viral eligibility in Australia | Health | The Guardian
![Could oral antiviral pills be a game-changer for COVID-19? An infectious disease physician explains why these options are badly needed Could oral antiviral pills be a game-changer for COVID-19? An infectious disease physician explains why these options are badly needed](https://images.theconversation.com/files/430413/original/file-20211104-19-tij9pk.jpg?ixlib=rb-1.1.0&rect=25%2C16%2C5582%2C3715&q=20&auto=format&w=320&fit=clip&dpr=2&usm=12&cs=strip)
Could oral antiviral pills be a game-changer for COVID-19? An infectious disease physician explains why these options are badly needed
Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study | PLOS ONE
![Antiviral Drug (Part-02)= Classification with MOA of Antiviral Drug | With FREE Online Test Link - YouTube Antiviral Drug (Part-02)= Classification with MOA of Antiviral Drug | With FREE Online Test Link - YouTube](https://i.ytimg.com/vi/K2tYiaxdFEQ/maxresdefault.jpg)
Antiviral Drug (Part-02)= Classification with MOA of Antiviral Drug | With FREE Online Test Link - YouTube
![Treatments like sotrovimab, molnupiravir, Paxlovid and Evusheld could lead to a new strategy in 2022: tackling covid-19 soon after infection to prevent severe symptoms from developing | New Scientist Treatments like sotrovimab, molnupiravir, Paxlovid and Evusheld could lead to a new strategy in 2022: tackling covid-19 soon after infection to prevent severe symptoms from developing | New Scientist](https://images.newscientist.com/wp-content/uploads/2021/12/24105606/PRI_216064136.jpg?crop=1:1,smart&width=1200&height=1200&upscale=true)
Treatments like sotrovimab, molnupiravir, Paxlovid and Evusheld could lead to a new strategy in 2022: tackling covid-19 soon after infection to prevent severe symptoms from developing | New Scientist
![Potential Emergence of Antiviral-Resistant Pandemic Viruses via Environmental Drug Exposure of Animal Reservoirs | Environmental Science & Technology Potential Emergence of Antiviral-Resistant Pandemic Viruses via Environmental Drug Exposure of Animal Reservoirs | Environmental Science & Technology](https://pubs.acs.org/cms/10.1021/acs.est.0c03105/asset/images/large/es0c03105_0001.jpeg)
Potential Emergence of Antiviral-Resistant Pandemic Viruses via Environmental Drug Exposure of Animal Reservoirs | Environmental Science & Technology
![Calls to expand access to Covid antivirals in Australia splits experts and doctors | Health | The Guardian Calls to expand access to Covid antivirals in Australia splits experts and doctors | Health | The Guardian](https://i.guim.co.uk/img/media/4d177eb17d8202a4e3e91e495c3a47b814641d71/0_134_3500_2101/master/3500.jpg?width=465&quality=85&dpr=1&s=none)
Calls to expand access to Covid antivirals in Australia splits experts and doctors | Health | The Guardian
![Vaccinated, low-risk people won't benefit from COVID-19 pill Paxlovid: Pfizer study suggests - ABC News Vaccinated, low-risk people won't benefit from COVID-19 pill Paxlovid: Pfizer study suggests - ABC News](https://s.abcnews.com/images/Health/paxlovid-rt-ps-220622_1655910142927_hpMain_16x9_992.jpg)
Vaccinated, low-risk people won't benefit from COVID-19 pill Paxlovid: Pfizer study suggests - ABC News
![Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies | SpringerLink Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13346-019-00691-6/MediaObjects/13346_2019_691_Fig1_HTML.png)